Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)
Clinical trial NCT05966025 · UNKNOWN
Trial details
- NCT number
- NCT05966025
- Sponsor
- October 6 University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-28
- Primary completion
- 2024-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.